◆ Controlled pilot

Brand names for a molecule, with the evidence behind each one.

ONOMA proposes brand names for a molecule and shows the evidence behind every one: the registered brands that set the precedent, the dictionary roots that carry the meaning, and the screens each name passed. It runs against a governed SFDA register of 12,486 brand rows. Dossier export and multi-reviewer workflow are not built yet, and are named below rather than implied.

◆ Server-verified workspace access◆ Governed registry integrity prerequisite◆ Advisory pilot — not a regulatory decision
Current scope

What it does, and what it does not

1

Verify access

Server-verified accounts and company access with no local workspace fallback.

2

Check conflicts

Exact and similarity checking against the governed register, with the five nearest registered brands named and scored on every candidate.

3

Fail closed

No result is calculated when the account, tenant, registry version, count or digest cannot be verified.

4

Generation

Three routes, live: INN-anchored names with the registered brands that carry each fragment, crafted names with their dictionary roots, and generated names. 94 molecules across 19 therapeutic areas, 73 of them reaching 20 or more INN-anchored options; the rest carry a recorded reason. Every name passes the WHO stem deny-list, the live similarity floor and the cultural screens.

5

Dossier & workflow

Not built. A shortlist lives in your browser, not in your workspace, so there is no export and no second reviewer yet. This is the next thing to build, and it is written down rather than implied.

6

Decision status

Advisory screening support only. The relevant health authority makes the regulatory decision.

Pilot access

Open ONOMA

Secure controlled pilot

For approved pilot accounts. Provides the limited registry-conflict check described above.

Open secure pilot ▸

Synthetic demonstration

An invented, offline example. For the real thing on a real molecule, use the live demo above.

See it on a real molecule ▸ Try synthetic demo ▸

Every limit on this page is a control, not an omission: names are refused when the register cannot be verified, when a WHO stem would be minted, or when the evidence is stale. No regulatory-acceptance probability or threshold is claimed. ONOMA advises; the relevant health authority decides.

The Veridiqa family

Part of a connected suite